ArticleJournal of pharmacy & bioallied sciences2024
Analysis of Long-Term Success and Biological Complications in Zygomatic Implant-Supported Prostheses.
Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bone Resorption Assessment Following Zygomatic Implants Surgery over 10 Years of Follow-Up.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Patients with significant maxillary atrophy who are not candidates for standard implants now have an option thanks to zygomatic implants. Long-term statistics on difficulties and success are, however, scarce. Methods: A tertiary care center's patient data were retrospectively analyzed. Included were patients who underwent zygomatic implant surgery between 2017 and 2022. This research gathered and examined data on follow-up, surgical techniques, complications, demographics, and implant features. Findings: There were 100 patients in all. 92% of the implants were successful, and 92 of them survived. Peri-implantitis (20%), soft tissue dehiscence (15%), sinusitis (10%), prosthesis fracture (8%), and infection (5%), were among the biological consequences. In summary, zygomatic implants have the potential to help individuals with severe maxillary atrophy recover, but close observation and effective management of any problems are necessary to maximize results. To enhance patient care and improve treatment regimens, further research is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.